Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-11-30Clinical Trial Update: Pemetrexed, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer [Phase 1]
Phase 1 trial evaluating pemetrexed, gemcitabine, and radiation therapy in locally advanced pancreatic cancer; study terminated with results…
-
CLINICAL_TRIALS trial_result · 2018-11-30Clinical Trial Update: Study of Gemcitabine + PEGPH20 vs Gemcitabine Alone in Stage IV Previously Untreated Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 study evaluating gemcitabine with PEGPH20 versus gemcitabine alone in stage IV pancreatic cancer has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2018-11-19Clinical Trial Update: A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial update for LY2090314 with chemotherapy in metastatic pancreatic cancer (Phase 1/2) terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-15Clinical Trial Update: BP-C1 in Short-term Treatment of Metastatic Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update for BP-C1 in metastatic/unresectable pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]
Phase 2 clinical trial updating gemcitabine and celecoxib in metastatic pancreatic cancer completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-10-29Clinical Trial Update: Gemcitabine, Bevacizumab, and Abdominal Radiation Therapy in Treating Patients With Localized Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine, bevacizumab, and abdominal radiation therapy in localized pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-26Clinical Trial Update: Gemcitabine, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial evaluating gemcitabine, capecitabine, and radiation therapy for locally advanced pancreatic cancer not amenable to surgery.
-
CLINICAL_TRIALS trial_result · 2018-10-25Clinical Trial Update: Dolastatin 10 in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update for dolastatin 10 in metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2018-10-15Clinical Trial Update: A Japanese Phase 1 Trial of TH-302 in Subjects With Solid Tumors and Pancreatic Cancer [Phase 1]
A Phase 1 trial update for TH-302 in subjects with solid tumors and pancreatic cancer has completed enrollment with results posted.
-
CLINICAL_TRIALS trial_result · 2018-10-10Clinical Trial Update: MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors [Phase 2]
Phase 2 clinical trial update of durvalumab (MEDI4736) in patients with brain metastases from epithelial-derived tumors, with terminated sta…
-
CLINICAL_TRIALS trial_result · 2018-10-09Clinical Trial Update: Simultaneous Resection of Pancreatic Cancer and Liver Oligometastasis After Induction Chemotherapy [Phase 3]
A Phase 3 trial evaluating simultaneous surgical resection of pancreatic cancer and liver oligometastases after induction chemotherapy.
-
CLINICAL_TRIALS trial_result · 2018-10-01Clinical Trial Update: Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial [Phase 1]
Phase 1 trial evaluating regional chemotherapy in unresectable or borderline resectable locally advanced pancreatic cancer completed with re…
-
CLINICAL_TRIALS trial_result · 2018-09-19Clinical Trial Update: A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer [Phase 1]
Phase 1 trial evaluating cabozantinib in combination with gemcitabine for advanced pancreatic cancer has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-09-19Clinical Trial Update: Apatinib Combined With S-1 in the Second-line Treatment of Advanced Pancreatic Cancer [Phase 2]
A phase 2 trial evaluating apatinib in combination with S-1 as second-line treatment for advanced pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2018-09-18Clinical Trial Update: A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer [Phase 2]
Phase 2 trial investigating MM-141 in combination with nab-paclitaxel and gemcitabine in frontline metastatic pancreatic cancer has complete…
-
CLINICAL_TRIALS trial_result · 2018-09-14Clinical Trial Update: 3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update investigating 3-AP and gemcitabine in recurrent, unresectable, or metastatic pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2018-09-14Clinical Trial Update: Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer [Phase 2]
Phase 2 trial evaluating combination chemotherapy plus interferon alfa followed by filgrastim in gastrointestinal tract cancers, completed.
-
CLINICAL_TRIALS trial_result · 2018-09-07Clinical Trial Update: Study of Sirolimus in Patients With Advanced Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial update for sirolimus in advanced pancreatic cancer (Phase 1/Phase 2) with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2018-09-06Clinical Trial Update: Opioid Growth Factor in Treating Patients With Advanced Pancreatic Cancer That Cannot Be Removed By Surgery [Phase 2]
Phase 2 clinical trial update for opioid growth factor in patients with advanced, unresectable pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2018-08-28Clinical Trial Update: Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca [Phase 2]
Phase 2 trial evaluating intravenous vitamin C in combination with standard chemotherapy for Stage IV pancreatic cancer; the study was termi…
-
CLINICAL_TRIALS trial_result · 2018-08-27Clinical Trial Update: Individualized Drug Treatment for Treating Patients With Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial update on individualized drug treatment for pancreatic cancer was terminated, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-22Clinical Trial Update: Efficacy Evaluation of Sequential Treatment With AG and Modified Folfirinox in Metastatic Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Clinical trial update evaluating sequential AG and modified Folfirinox in metastatic pancreatic adenocarcinoma; phase 1/2 with unknown statu…
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: Nab-paclitaxel Plus S-1(AS) Versus Nab-paclitaxel Plus Gemcitabine(AG) in Patients With Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial update comparing nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine in advanced pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2018-08-08Clinical Trial Update: A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients [Phase 2]
Phase 2 trial evaluating neoadjuvant FOLFIRINOX and FDR-Gemcitabine with concurrent IMRT in pancreatic cancer has completed with posted resu…
-
CLINICAL_TRIALS trial_result · 2018-08-08Clinical Trial Update: Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal Adenocarcinoma [Phase 2]
Phase 2 trial evaluating gemcitabine and Abraxane plus placebo vs with demcizumab in first-line metastatic pancreatic ductal adenocarcinoma;…